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The symptoms of eclampsia, a Greek word meaning “lightning” have been known to 
medicine since Hippocrates (460-370 BC) but it is only in the 18th century that 
physicians made a distinction between eclampsia and epilepsy (Bell MJ J Obstet 
Gynecol Neonatal Nurs 2010;39:510-8). Eclampsia/preeclampsia results from a 
disorder of placentation characterised by insufficient transformation of the spiral 
arteries at the level of the placental bed. The trophoblastic invasion is sufficient to 
allow early pregnancy phases of placentation but too shallow for complete 
transformation of the arterial utero-placental circulation. Heritable paternal imprinting 
of the genome is necessary for normal trophoblast development. Several large 
cohort studies have identified paternal SNPs with strong associations with 
preeclampsia, in particular in the paternally expressed genes affecting placentation 
(Dekker G et al., J Reprod Immuno 2011;89:126-32). We have proposed that 
eclampsia/pre-eclampsia is three-stage disorder with the primary pathology being an 
excessive or atypical maternal immune response, which impairs placentation leading 
to placental chronic oxidative stress and subsequently to diffuse maternal endothelial 
cell dysfunction. (Jauniaux E et al, Hum Reprod 2006;12:747-55). 
 
For centuries the diagnosis of eclampsia or Toxemia was exclusively based on the 
presence of maternal convulsions before or after delivery. Other symptoms such as 
headache, hypogastric pain, temporary loss of vision and severe oedema were 
recognised by the mid 19th century suggesting that a prodromal stage existed before 
eclampsia. Pierre Rayer (1793-1867), a French physician was the first to describe 
proteinuria in eclamptic women and John Lever (1811-1859), an English physician is 
credited to be the first to have shown that eclampsia-associated proteinuria was 
specific to the disease (Bell MJ J Obstet Gynecol Neonatal Nurs 2010;39:510-8). 
Modern blood pressure measurement became available, when Nikolai Korotkov 
(1874-1920), a Russian vascular surgeon discovered the difference between systolic 
and diastolic blood pressure. Urine analysis and blood pressure measurements 
started to be use at the beginning of the 20th century (Corbett D BJOG 1913;23:227-
37). These discoveries made it possible to identify women at risk of eclamptic 
convulsion and the concept of preeclampsia started to appear in the modern medical 
literature.   
Eclampsia remains a major cause of maternal mortality in developing countries but in 
developed countries screening programs including routine blood pressure 
measurements and uninalysis were introduced in the 1960s to detect pregnant 
women at the preeclamptic stage. The development of Doppler ultrasound in the 
1980s and more recently the use of new maternal serum markers have made limited 
alterations in the management of preeclampsia. A recent systematic review of 
studies reporting risk prediction models for preeclampsia, including uterine Doppler 
measurements has found frequent methodological deficiencies, thus limiting their 
reliability and validity (Brunelli VB et al, 2015 BJOG;122:904-14). Risk factors for 
preeclampsia such as kidney disorders, diabetes, multiple gestation pregnancy 
chronic hypertension, previous history of preeclampsia have been identified over the 
last four decades but for the general population of pregnant women the screening 
and management of preeclampsia has changed very little and is essentially based 
on observation, anti-hypertensive drugs, magnesium sulfate (popularised in the 
1920s) and delivery before the eclamptic stage.  
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